4.6 Article

Se-Methylselenocysteine (SMC) Improves Cognitive Deficits by Attenuating Synaptic and Metabolic Abnormalities in Alzheimer's Mice Model: A Proteomic Study

期刊

ACS CHEMICAL NEUROSCIENCE
卷 12, 期 7, 页码 1112-1132

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acschemneuro.0c00549

关键词

Alzheimer's disease (AD); Se-methylselenocysteine (SMC); iTRAQ

资金

  1. National Natural Science Foundation of China [21771126, 31870825]
  2. Shenzhen Bureau of Science, Technology and Information [JCYJ20180305124000597, JCYJ20170412110026229]
  3. Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions [2019SHIBS0003]
  4. National Key Research and Development Program of China [2018YFE0118900]

向作者/读者索取更多资源

The study found that Se-methylselenocysteine (SMC) can reverse the pathological phenomena of metabolic disorders, synaptic dysfunction, and oxidative stress in an Alzheimer's disease mouse model. After SMC treatment, the expression of related proteins was reversed, which may be the main mechanism of SMC intervention in AD.
Se-methylselenocysteine (SMC) is a major selenocompound in selenium (Se) enriched plants and has been found to ameliorate neuropathology and cognitive deficits in triple-transgenic mice model of Alzheimer's disease (3 x Tg-AD mice). To explore the underlying molecular mechanisms, the present study is designed to elucidate the protein changes in the cortex of SMC-treated 3 x Tg-AD mice. After SMC supplementation, proteomic analysis revealed that 181, 271, and 41 proteins were identified as differentially expressed proteins (DEPs) between 3 x Tg-AD mice vs wild type (AD/WT group), SMC-treated AD mice vs AD (AD + SMC/AD), and AD + SMC/WT group, respectively. Among these, 138 proteins in the diseased group were reversed by SMC treatment. The DEPs in AD/WT group and AD + SMC/AD group were mainly related to metabolism, synapses, and antioxidant proteins, while their levels were decreased in AD mice but up-regulated after treating with SMC. In addition, we found reduced ATP levels and destroyed synaptic structures in the AD mice brains, which were significantly ameliorated upon SMC treatment. Our study suggests that energy metabolism disorders, abnormal amino acid metabolism, synaptic dysfunction, and oxidative stress may be the key pathogenic phenomena of AD. SMC reversed the expression of proteins associated with them, which might be the main mechanism of its intervention in AD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Proteomic Profiling of Cerebrum Mitochondria, Myelin Sheath, and Synaptosome Revealed Mitochondrial Damage and Synaptic Impairments in Association with 3 x Tg-AD Mice Model

Liming Shen, Aochu Yang, Xinqian Chen, Shifeng Xiao, Xukun Liu, Jing Lin, Yuxi Zhao, Kaoyuan Zhang, Cuihua Li, Junyan Ke, Huajie Zhang, Naseer Ullah Khan

Summary: Alzheimer's disease is the most common age-associated dementia with complex pathological hallmarks, and proteomics analysis revealed vulnerable subcellular components and differential protein expression between AD and WT mice; these findings suggest that early events of AD involve decreased energy metabolism, impaired neurotransmitter synthesis, and changes in cytoskeletal proteins.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2022)

Review Oncology

Synthesis of gold nanorods and their performance in the field of cancer cell imaging and photothermal therapy

Naseer Ullah Khan, Jing Lin, Muhammad Rizwan Younas, Xukun Liu, Liming Shen

Summary: Gold nanorods with unique optical properties have attracted interest in biomedical field for their potential in simultaneous light-mediated imaging and photothermal cancer treatment. Seed-mediated growth method is commonly used for synthesizing gold nanorods with specific shape and properties for biomedical applications.

CANCER NANOTECHNOLOGY (2021)

Article Biochemistry & Molecular Biology

iTRAQ-Based Proteomics Analysis of Rat Cerebral Cortex Exposed to Valproic Acid before Delivery

Jing Lin, Kaoyuan Zhang, Xueshan Cao, Yuxi Zhao, Naseer Ullah Khan, Xukun Liu, Xiaoxiao Tang, Margy Chen, Huajie Zhang, Liming Shen

Summary: The study identified 79 differentially expressed proteins in the cerebral cortex of VPA rat model, mainly enriched at synapses and involved in energy metabolism, thyroid hormone synthesis pathway, and cytoskeleton. The dysregulation of these proteins may contribute to autism-like behavior in rats, as well as being associated with neuropsychiatric disorders. Increased expression of proteins related to energy metabolism suggests ASD may involve mitochondrial dysfunction that requires further investigation.

ACS CHEMICAL NEUROSCIENCE (2022)

Article Neurosciences

Deep transfer learning of structural magnetic resonance imaging fused with blood parameters improves brain age prediction

Bingyu Ren, Yingtong Wu, Liumei Huang, Zhiguo Zhang, Bingsheng Huang, Huajie Zhang, Jinting Ma, Bing Li, Xukun Liu, Guangyao Wu, Jian Zhang, Liming Shen, Qiong Liu, Jiazuan Ni

Summary: Machine learning models combining brain structural MRI data and blood parameters show promising potential in accurately predicting brain age, with better performance in older age groups. The fusion model achieved a more accurate prediction of brain age by incorporating multiple indicators, showing significant improvements in evaluating brain health based on MRI and blood parameters.

HUMAN BRAIN MAPPING (2022)

Article Endocrinology & Metabolism

Potential biomarkers identified in plasma of patients with gestational diabetes mellitus

Huajie Zhang, Yuxi Zhao, Danqing Zhao, Xinqian Chen, Naseer Ullah Khan, Xukun Liu, Qihong Zheng, Yi Liang, Yuhua Zhu, Javed Iqbal, Jing Lin, Liming Shen

Summary: The study aimed to identify plasma metabolites that can be used as potential biomarkers for GDM, and to clarify GDM-related mechanisms. Differential metabolites in the plasma of GDM pregnant women at 12-16 weeks and 24-28 weeks of pregnancy were identified, some of which may serve as potential biomarkers for GDM prediction and diagnosis. Abnormal amino acid metabolism and lipid metabolism in patients with GDM may be related to GDM pathogenesis.

METABOLOMICS (2021)

Article Endocrinology & Metabolism

Metabolic characteristics of plasma bile acids in patients with intrahepatic cholestasis of pregnancy-mass spectrometric study

Qihong Zheng, Liming Shen, Danqing Zhao, Huajie Zhang, Yi Liang, Yuhua Zhu, Naseer Ullah Khan, Xukun Liu, Jun Zhang, Jing Lin, Xiaoxiao Tang

Summary: The study investigated changes in plasma bile acid (BAs) metabolic profile in pregnant women with intrahepatic cholestasis of pregnancy (ICP) to find biomarkers for diagnosis and grading, and explore disease mechanism. Significant differences in plasma BA profiles were found between ICP patients and controls, with potential diagnostic and grading markers identified. A characteristic of ICP patients was an increase in conjugated BAs.

METABOLOMICS (2021)

Correction Chemistry, Multidisciplinary

Ultrasensitive Detection of Exosome Using Biofunctionalized Gold Nanorods on a Silver-Island Film (vol 21, pg 5532, 2021)

Naseer Ullah Khan, Zahir Muhammad, Xukun Liu, Jing Lin, Qihong Zheng, Huajie Zhang, Samiullah Malik, Hua He, Liming Shen

NANO LETTERS (2022)

Article Neurosciences

A Combined Proteomics and Metabolomics Profiling to Investigate the Genetic Heterogeneity of Autistic Children

Liming Shen, Huajie Zhang, Jing Lin, Yan Gao, Margy Chen, Naseer Ullah Khan, Xiaoxiao Tang, Qi Hong, Chengyun Feng, Yuxi Zhao, Xueshan Cao

Summary: This study conducted genetic testing and biomarker analysis in children with ASD, finding that the differential expressions of proteins and metabolites in plasma and PBMCs could effectively distinguish autistic children from healthy controls. Mechanistic analysis suggested that glycerophospholipid metabolism and N-glycan biosynthesis might play critical roles in the pathogenesis of ASD.

MOLECULAR NEUROBIOLOGY (2022)

Article Biochemistry & Molecular Biology

Investigating the Neurotoxic Impacts of Arsenic and the Neuroprotective Effects of Dictyophora Polysaccharide Using SWATH-MS-Based Proteomics

Jun Zhang, Ting Hu, Yi Wang, Xinglai Zhang, Huajie Zhang, Jing Lin, Xiaoxiao Tang, Xukun Liu, Margy Chen, Naseer Ullah Khan, Liming Shen, Peng Luo

Summary: Arsenic is an important toxic element in the environment, and its effects on the brain are still limitedly studied. This study used proteomics to reveal the mechanism of arsenic neurotoxicity in rats and the protective effect of dictyophora polysaccharide.

MOLECULES (2022)

Review Psychiatry

Oxidative Stress in Autism Spectrum Disorder-Current Progress of Mechanisms and Biomarkers

Xukun Liu, Jing Lin, Huajie Zhang, Naseer Ullah Khan, Jun Zhang, Xiaoxiao Tang, Xueshan Cao, Liming Shen

Summary: Autism spectrum disorder is a neurodevelopmental disorder with increasing diagnoses worldwide. Early diagnosis and intervention can improve outcomes. However, there are no clinical biomarkers for ASD. Recent studies have found a link between ASD and oxidative stress, and identified potential biomarkers to detect oxidative stress.

FRONTIERS IN PSYCHIATRY (2022)

Article Neurosciences

Targeted Metabolomic Analysis of the Eye Tissue of Triple Transgenic Alzheimer's Disease Mice at an Early Pathological Stage

Liming Shen, Xiaoxiao Tang, Huajie Zhang, Hongbin Zhuang, Jing Lin, Yuxi Zhao, Xukun Liu

Summary: This study analyzed the eye tissues of 2- and 6-month-old triple transgenic AD (3 x Tg-AD) male mice and identified differential metabolites associated with various metabolic pathways. The results showed that the eye tissues of 3 x Tg-AD mice underwent changes in the early stages of the disease, and these changes were more pronounced at 6 months of age. The joint analysis with previous hippocampal study revealed similar differential metabolites and mechanisms, but with tissue specificity.

MOLECULAR NEUROBIOLOGY (2023)

Review Biochemical Research Methods

Subcellular proteomics insights into Alzheimer & apos;s disease development

Zhiyuan Liang, Hongbin Zhuang, Xueshan Cao, Guanwei Ma, Liming Shen

Summary: Alzheimer's disease is a neurodegenerative disease characterized by cognitive impairment and decreased judgment function. There is currently no specific and effective therapeutic agent due to incomplete understanding of its molecular mechanisms. Proteomics studies have made advances in understanding the mechanism, diagnostic markers, and drug targets of Alzheimer's disease. These studies provide insights into the pathology of Alzheimer's disease and offer potential new biomarkers and drug targets.

PROTEOMICS CLINICAL APPLICATIONS (2023)

暂无数据